Public deck

Neurocrine: the neuroscience cash engine still has to broaden beyond one franchise

Neurocrine reported FY2025 revenue of $2.86 billion and Q1 2026 revenue of $815 million, making the thesis about whether profitable neuroscience growth can broaden while pipeline and commercialization risk stay controlled.